Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol

키워드

참고문헌 (49)

1. Goldstein DE, "Tests of glycemia in diabetes", Diabetes Care, 18, pp.896~909 (1995)
2. International Expert Committee, "International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes", Diabetes Care, 32, pp.1327~1334 (2009)
3. "Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO Consultation", diabetes mellitus: abbreviated report of a WHO Consultation. Geneva: World Health Organization, ~ (2011)
4. Radin MS., "Pitfalls in hemoglobin A1c measurement: when results may be misleading", J Gen Intern Med, 29, pp.388~394 (2014)
5. Parrinello CM, "Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management", Curr Diab Rep, 14, pp.548~ (2014)
6. "Factors that Interfere with HbA1c test results" (2011)[URL]
7. Polgreen PM, "Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus", Clin Infect Dis, 37, pp.e53~e56 (2003)
8. Brown JN, "Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis", Pharmacotherapy, 29, pp.468~472 (2009)
9. Ly J, "Red blood cell survival in chronic renal failure", Am J Kidney Dis, 44, pp.715~719 (2004)
10. Suzuki S, "Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants", Pediatr Diabetes, 14, pp.267~272 (2013)
11. Suzuki S, "Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus", Diabetologia, 54, pp.2247~2253 (2011)
12. Koga M, "Prediction of nearfuture glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes", J Diabetes Investig, 2, pp.304~309 (2011)
13. Imagawa A, "A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group", N Engl J Med, 342, pp.301~307 (2000)
14. "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus", N Engl J Med, 329, pp.977~986 (1993), The Diabetes Control and Complications Trial Research Group
15. Wang PH, "Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes", Lancet, 341, pp.1306~1309 (1993)
16. Reichard P, "The effect of longterm intensified insulin treatment on the development of microvascular complications of diabetes mellitus", N Engl J Med, 329, pp.304~309 (1993)
17. Mosca A, "Plasma protein glycation as measured by fructosamine assay", Clin Chem, 33, pp.1141~1146 (1987)
18. Pandya HC, "Serum fructosamine as an index of glycaemia:comparison with glycated haemoglobin in diabetic and non-diabetic individuals", Pract Diabetes Int, 4, pp.126~128 (1987)
19. Narbonne H, "Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?", Diabetes Metab, 27(5 Pt 1), pp.598~603 (2001)
20. Matsumoto H, "Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1diabetes", Intern Med, 51, pp.1315~1321 (2012)
21. Howey JE, "Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation", Clin Chem, 33(2 Pt 1), pp.269~272 (1987)
22. Miyazaki A, "Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin", Ann Clin Biochem, 49(Pt 5), pp.441~444 (2012)
23. Kim D, "The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function", Clin Endocrinol (Oxf), 77, pp.679~683 (2012)
24. Koga M, "Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia", Clin Chim Acta, 412, pp.253~257 (2011)
25. Juraschek SP, "Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose", Clin Chem, 58, pp.1648~1655 (2012)
26. 이지우, "Serum glycated albumin as a new glycemic marker in pediatric diabetes", Annals of Pediatirc Endocrinology & Metabolism, 18(4), pp.208~213 (2013), 대한소아내분비학회
27. Shin YS, "Significance of the measurement of serum fructosamine in the management of childhood diabetes", Int J Pediatr Endocrinol, 2013(Suppl 1), pp.P36~ (2013)
28. Koga M, "Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus", J Diabetes Complications, 27, pp.211~213 (2013)
29. Hirsch IB, "Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications", JAMA, 303, pp.2291~2292 (2010)
30. Chon S, "Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus", Diabetes Technol Ther, 15, pp.455~460 (2013)
31. Koga M, "Evaluation of the glycated albumin", HbA1c ratio by stage of diabetic nephropathy, 2011, pp.2, 141~145
32. Koga M, "Effects of thyroid hormone on serum glycated albumin levels:study on non-diabetic subjects", Diabetes Res Clin Pract, 84, pp.163~167 (2009)
33. Suzuki S, "Glycated albumin in patients with neonatal diabetes mellitus is apparently low in relation to glycemia compared with that in patients with type 1 diabetes mellitus", Horm Res Paediatr, 77, pp.273~276 (2012)
34. Koga M., "Glycated albumin: clinical usefulness", Clin Chim Acta, 433, pp.96~104 (2014)
35. Koga M, "Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients", Endocr J, 53, pp.387~391 (2006)
36. Suzuki S, "Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin", Pediatr Diabetes, 14, pp.25~30 (2013)
37. Yamanouchi T, "Serum 1,5-anhydroglucitol (1,5AG): new clinical marker for glycemic control", Diabetes Res Clin Pract, 24(Suppl), pp.S261~S268 (1994)
38. Buse JB, "Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker", Diabetes Technol Ther, 5, pp.355~363 (2003)
39. Dungan KM., "1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions", Expert Rev Mol Diagn, 8, pp.9~19 (2008)
40. Yamanouchi T, "Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients", Diabetes, 38, pp.723~729 (1989)
41. Stettler C, "Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients", Diabetes Care, 31, pp.1534~1535 (2008)
42. Kishimoto M, "1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM", Diabetes Care, 18, pp.1156~1159 (1995)
43. McGill JB, "Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay", Diabetes Care, 27, pp.1859~1865 (2004)
44. Dungan KM, "1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes", Diabetes Care, 29, pp.1214~1219 (2006)
45. 석한나, "1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes", Diabetes and Metabolism Journal, 39(2), pp.164~170 (2015), 대한당뇨병학회
46. Chiang JL, "Type 1Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association", Diabetes Care, 37, pp.2034~2054 (2014)
47. Juraschek SP, "Alternative markers of hyperglycemia and risk of diabetes", Diabetes Care, 35, pp.2265~2270 (2012)
48. Rondeau P, "The glycation of albumin: structural and functional impacts", Biochimie, 93, pp.645~658 (2011)
49. Goldstein DE, "Tests of glycemia in diabetes", Diabetes Care, 27, pp.1761~1773 (2004)

관련 논문AI추천